Covered recipient · General Payments record
LILIT BALTAIAN
General Payments · PY2018–2024
$3,889.54
- Reported across 218 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $255.57 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $192.16 | 13 |
| Lilly USA, LLC | $29.30 | 1 |
| Novo Nordisk AS | $17.66 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $5.46 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196976 | CMS |
| Amgen Inc. | $23.16 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111523733 | CMS |
| Amgen Inc. | $30.63 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111523735 | CMS |
| Amgen Inc. | $5.93 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196978 | CMS |
| Amgen Inc. | $19.21 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196980 | CMS |
| Amgen Inc. | $17.58 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111523737 | CMS |
| Amgen Inc. | $26.45 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111523739 | CMS |
| Amgen Inc. | $6.81 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196982 | CMS |
| Amgen Inc. | $5.33 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196984 | CMS |
| Amgen Inc. | $5.73 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196986 | CMS |
| Amgen Inc. | $7.69 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196988 | CMS |
| Amgen Inc. | $6.47 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117196990 | CMS |
| Amgen Inc. | $31.71 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111523741 | CMS |
| Lilly USA, LLC | $29.30 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135131586 | CMS |
| Novo Nordisk Inc | $17.66 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108578993 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.45 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153484240 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.